These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12684503)

  • 1. Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity.
    Kuwasako K; Kitamura K; Nagoshi Y; Cao YN; Eto T
    J Biol Chem; 2003 Jun; 278(25):22623-30. PubMed ID: 12684503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor.
    Steiner S; Muff R; Gujer R; Fischer JA; Born W
    Biochemistry; 2002 Sep; 41(38):11398-404. PubMed ID: 12234182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptors.
    Kuwasako K; Cao YN; Chu CP; Iwatsubo S; Eto T; Kitamura K
    J Biol Chem; 2006 Mar; 281(11):7205-13. PubMed ID: 16410241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors.
    Kuwasako K; Kitamura K; Ito K; Uemura T; Yanagita Y; Kato J; Sakata T; Eto T
    J Biol Chem; 2001 Dec; 276(52):49459-65. PubMed ID: 11591721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.
    Hilairet S; Foord SM; Marshall FH; Bouvier M
    J Biol Chem; 2001 Aug; 276(31):29575-81. PubMed ID: 11387328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
    Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
    Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling.
    Kamitani S; Sakata T
    Biochim Biophys Acta; 2001 May; 1539(1-2):131-9. PubMed ID: 11389975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus.
    Nikitenko LL; Brown NS; Smith DM; MacKenzie IZ; Bicknell R; Rees MC
    Mol Hum Reprod; 2001 Jul; 7(7):655-64. PubMed ID: 11420389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
    Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
    J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
    Kikumoto K; Katafuchi T; Minamino N
    Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
    Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
    Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function.
    Husmann K; Sexton PM; Fischer JA; Born W
    Mol Cell Endocrinol; 2000 Apr; 162(1-2):35-43. PubMed ID: 10854696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor.
    Nagoshi Y; Kuwasako K; Ito K; Uemura T; Kato J; Kitamura K; Eto T
    Eur J Pharmacol; 2002 Aug; 450(3):237-43. PubMed ID: 12208315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
    Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
    J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
    Moad HE; Pioszak AA
    Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells.
    Aldecoa A; Gujer R; Fischer JA; Born W
    FEBS Lett; 2000 Apr; 471(2-3):156-60. PubMed ID: 10767413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function analysis of RAMP1 by alanine mutagenesis.
    Simms J; Hay DL; Bailey RJ; Konycheva G; Bailey G; Wheatley M; Poyner DR
    Biochemistry; 2009 Jan; 48(1):198-205. PubMed ID: 19072332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function of conserved cysteine residues in the extracellular domain of human receptor-activity-modifying protein.
    Steiner S; Born W; Fischer JA; Muff R
    FEBS Lett; 2003 Dec; 555(2):285-90. PubMed ID: 14644429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure.
    Cueille C; Pidoux E; de Vernejoul MC; Ventura-Clapier R; Garel JM
    Biochem Biophys Res Commun; 2002 Jun; 294(2):340-6. PubMed ID: 12051717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.